Clinical Trial Update: Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Effexor XR in Chinese subjects with major depressive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Effexor XR (venlafaxine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Major Depressive Disorder | Phase 4 | Status: WITHDRAWN